LCOR expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.485000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.225800E-01
Normal-vs-Stage2
9.408800E-01
Normal-vs-Stage3
1.932990E-01
Normal-vs-Stage4
3.255200E-01
Stage1-vs-Stage2
8.386400E-01
Stage1-vs-Stage3
1.343960E-01
Stage1-vs-Stage4
2.247200E-01
Stage2-vs-Stage3
2.014600E-01
Stage2-vs-Stage4
2.800400E-02
Stage3-vs-Stage4
1.403370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.630200E-01
Normal-vs-AfricanAmerican
5.444800E-01
Normal-vs-Asian
6.501400E-01
Caucasian-vs-AfricanAmerican
2.725600E-01
Caucasian-vs-Asian
4.523400E-01
AfricanAmerican-vs-Asian
1.457390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.347800E-01
Normal-vs-Female
9.653000E-01
Male-vs-Female
9.237400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.663600E-01
Normal-vs-Age(41-60Yrs)
5.981800E-01
Normal-vs-Age(61-80Yrs)
8.631400E-01
Normal-vs-Age(81-100Yrs)
5.257800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.101000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.939800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.450400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.308220E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.493600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.654400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.087600E-01
Normal-vs-Daily Drinker
9.224800E-01
Normal-vs-Weekly Drinker
8.461800E-01
Normal-vs-Occasional Drinker
6.933400E-01
Normal-vs-Social Drinker
8.352400E-01
Non Drinker-vs-Daily Drinker
6.833400E-01
Non Drinker-vs-Weekly Drinker
8.465400E-01
Non Drinker-vs-Occasional Drinker
1.277390E-01
Non Drinker-vs-Social Drinker
1.777600E-01
Daily Drinker-vs-Weekly Drinker
8.876400E-01
Daily Drinker-vs-Occasional Drinker
3.584600E-01
Daily Drinker-vs-Social Drinker
6.203400E-01
Weekly Drinker-vs-Occasional Drinker
3.141200E-01
Weekly Drinker-vs-Social Drinker
5.069600E-01
Occasional Drinker-vs-Social Drinker
6.354600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.132400E-01
Normal-vs-Grade 2
1.217440E-01
Normal-vs-Grade 3
5.979600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.955000E-01
Grade 1-vs-Grade 3
6.980400E-01
Grade 1-vs-Grade 4
2.132400E-01
Grade 2-vs-Grade 3
5.685200E-01
Grade 2-vs-Grade 4
1.217440E-01
Grade 3-vs-Grade 4
5.979600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.286200E-01
Normal-vs-NonDiabetic
8.723800E-01
Diabetic-vs-NonDiabetic
8.250600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.959000E-01
Normal-vs-NoPancreatitis
9.312000E-01
Pancreatitis-vs-NoPancreatitis
6.810000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.691800E-01
Normal-vs-N1
9.202200E-01
N0-vs-N1
8.290400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.406400E-01
Normal-vs-TP53-NonMutant
7.092400E-01
TP53-Mutant-vs-TP53-NonMutant
9.913000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
